We are live on
!
Find out more
Nuvation Bio
NUVB
NUVB
160 hedge funds and large institutions have $526M invested in Nuvation Bio in 2024 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 63 increasing their positions, 36 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
75% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 36
32% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 22
23% more capital invested
Capital invested by funds: $429M → $526M (+$97.4M)
4% more funds holding
Funds holding: 154 → 160 (+6)
2.69% more ownership
Funds ownership: 56.07% → 58.75% (+2.7%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
100% less call options, than puts
Call options by funds: $3K | Put options by funds: $952K
Holders
160
Holders Change
+6
Holders Change %
+3.9%
% of All Funds
2.11%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
29
Increased
63
Reduced
36
Closed
22
Calls
$3K
Puts
$952K
Net Calls
-$949K
Net Calls Change
-$416K
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$41.3M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.7M |
| 3 |
LCM
Laurion Capital Management
New York
|
+$12.6M |
| 4 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$10.7M |
| 5 |
BlackRock
New York
|
+$4.04M |
Top Sellers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$44M |
| 2 |
OCA
Octagon Capital Advisors
New York
|
-$7.64M |
| 3 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$2.79M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.49M |
| 5 |
Renaissance Technologies
New York
|
-$1.19M |
